Santa Cruz Biotechnology delivers a wide array of IFN-α 13 Antibodies for investigating interferon alpha in immune responses. IFN-α 13 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).Interferon alpha 13 is a cytokine that plays a crucial role in the immune system, particularly in antiviral responses and the modulation of immune cell activity. IFN-α 13 is involved in the regulation of gene expression and can influence the proliferation and differentiation of various immune cells. Understanding IFN-α 13 function is essential for developing therapeutic strategies against viral infections and autoimmune diseases. Researchers can explore cellular signaling pathways and mechanisms through which IFN-α 13 mediates its biological effects. IFN-α 13 research has revealed significant insights into antiviral immunity and inflammatory responses. Advanced detection methods enable precise monitoring of IFN-α 13 expression and activity in diverse biological samples. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of immune system regulation and disease treatment.